Four Firms Vie For Medicare 2014 New-Tech Add-On Payments
This article was originally published in The Gray Sheet
Executive Summary
CMS held its annual new-technology Town Hall Feb. 5, hearing from applicants for a drug-eluting peripheral artery stent, a neurostimulator system for epilepsy seizures, a transcatheter mitral valve repair system and a retinal prosthesis system.
You may also be interested in...
Medicare Bonus Payments Awarded To Cook’s Stent, Second Sight’s Eye Implant
Cook Medical’s Zilver PTX stent and Second Sight Medical Products’ Argus II retinal prosthesis system will enjoy new-technology add-on payments in 2014 under CMS’ hospital inpatient prospective payment system final rule.
Medicare Bonus Payments Awarded To Cook’s Stent, Second Sight’s Eye Implant
Cook Medical’s Zilver PTX stent and Second Sight Medical Products’ Argus II retinal prosthesis system will enjoy new-technology add-on payments in 2014 under CMS’ hospital inpatient prospective payment system final rule.
FDA Advisors Vote That Benefits Of Abbott’s MitraClip Outweigh Risks
The agency’s Circulatory System Devices Panel narrowly voted in favor of Abbott’s MitraClip transcatheter mitral valve repair system to reduce mitral regurgitation. But the discussions about the clinical evidence on the technology were complex and the panel’s support for Abbott’s PMA was not unanimous.